Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (185)	11/9/2000 8:04:47 PM
From: Biomaven	Read Replies (1) \| Respond to of 724

Well I thought the extra stuff was accidental, but looking at the filing itself: This document (with additional portions of Section 1.6 omitted) was originally filed as Exhibit 10-18 to Registrant's Form 10-Q for period Ending June 30,1999] So the additions were deliberate, and I withdraw my "indiret" gibe. What else changed besides the part you mentioned? All I can think of is that there was a time limit embedded in some confidentiality agreement between DGI and Novo, and for some reason DGI wants this additional information out in the open now. Seems a stretch, but I can't think what else would prompt this. Still can't believe it's the SEC - we've all seen elided documents where practically all that was left was boilerplate and the occasional "provided that" floating amidst a sea of asterisks. Peter